Tuberculosis medical therapy special conditions: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) |
Joao Silva (talk | contribs) No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
==HIV Coinfection== | |||
<!-- | <!-- | ||
Recommendations for the treatment of tuberculosis in [[HIV]]-infected adults: | Recommendations for the treatment of tuberculosis in [[HIV]]-infected adults: | ||
| Line 25: | Line 24: | ||
--> | --> | ||
==Extrapulmonary== | |||
===Tuberculous Lymphadenitis=== | |||
===Skeletal Tuberculosis=== | |||
===Tuberculous Meningitis=== | |||
===Miliary Tuberculosis=== | |||
===Tuberculosis Peritonitis=== | |||
===Tuberculous Pericarditis=== | |||
===Renal Tuberculosis=== | |||
<!-- | <!-- | ||
According to the 4th edition of WHO recommendations; | According to the 4th edition of WHO recommendations; | ||
| Line 83: | Line 82: | ||
--> | --> | ||
==Liver Disease== | |||
==Referencies== | ==Referencies== | ||
Revision as of 14:41, 17 September 2014
|
Tuberculosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tuberculosis medical therapy special conditions On the Web |
|
American Roentgen Ray Society Images of Tuberculosis medical therapy special conditions |
|
Risk calculators and risk factors for Tuberculosis medical therapy special conditions |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]